Dexilant uses a dual delayed-release technology that provides two separate releases of dexlansoprazole, offering extended acid suppression with a single daily dose. This can simplify therapy for patients who struggle with twice-daily dosing required by some other PPIs.
Dexilant is a prescription medication; you should carry the original pharmacy label and, if possible, a copy of the prescription. In the UK and most other countries, PPIs are not considered controlled substances, so they generally pass security checks without issue.
Both strengths are white, film-coated pills, but the 60 mg capsule is slightly larger in diameter. Manufacturers imprint the dosage strength on the tablet surface, allowing easy identification.
Yes, occasional use of antacids (e.g., calcium carbonate) for breakthrough heartburn is acceptable. However, antacids can temporarily raise gastric pH, which might mask symptoms; discuss regular antacid use with your prescriber.
Most patients notice improvement within 2-3 days, but full healing of erosive oesophagitis may require 4-8 weeks of consistent therapy.
Long-term acid suppression can reduce absorption of certain nutrients, including vitamin B12 and non-heme iron. Periodic monitoring is advisable for patients on extended therapy.
Severe or persistent diarrhoea could signal a Clostridioides difficile infection, a known risk with prolonged PPI use. Seek medical evaluation promptly for appropriate testing and treatment.
Dexilant is prescribed by a qualified prescriber, typically a general practitioner or gastroenterologist. NHS coverage depends on clinical indication and local formulary decisions; your doctor can confirm eligibility.
Yes, Dexilant can be started directly after stopping another PPI. No washout is required because all PPIs work through the same mechanism and have similar half-lives.
Calcium carbonate may reduce the absorption of dexlansoprazole if taken simultaneously; it's advisable to separate dosing by at least two hours. Magnesium-containing supplements are generally safe but monitor serum levels if you use high-dose magnesium long term.
Dexilant is a prescription-only medication marketed in the United Kingdom by Takeda Pharmaceuticals. It contains the active ingredient dexlansoprazole, a proton-pump inhibitor (PPI) that belongs to the broader Digestive Health therapeutic class. Dexilant is supplied as a pill and is available in two strengths: 30 mg and 60 mg. The Medicines and Healthcare products Regulatory Agency (MHRA) classifies Dexilant as a prescription (POM) product and it is not available over the counter in the UK.
Dexlansoprazole belongs to the PPI family, which suppresses gastric acid production by irreversibly blocking the H⁺/K⁺-ATPase enzyme (the “proton pump”) located on the parietal cells of the stomach lining. Dexilant’s formulation uses a dual delayed-release technology:
This biphasic release creates a prolonged duration of action, typically lasting 24 hours, which helps to maintain a higher gastric pH and promotes healing of acid-related damage in the oesophagus.
Dexilant is approved by the MHRA for the following indications:
These approvals are based on clinical trials demonstrating that dexlansoprazole achieves high rates of mucosal healing and sustained symptom control, often with once-daily dosing.
Some clinicians consider dexlansoprazole for off-label indications when standard therapy is inadequate. Research has explored its role in:
These uses are not approved by the MHRA. Off-label prescribing requires careful risk-benefit assessment and should be supervised by a qualified healthcare professional.
Patients should always inform their prescriber of all medicines, herbal supplements, and over-the-counter products before starting Dexilant.
Standard dosing:
30 mg once daily for initial treatment of erosive oesophagitis.
60 mg once daily for maintenance therapy or for patients requiring higher acid suppression.
Administration: Swallow the pill whole with a glass of water. Do not chew, crush, or split the tablet, as this would disrupt the dual-release mechanism.
Timing: Dexilant may be taken at any time of day, but taking it at the same time each day helps maintain consistent acid control.
Missed dose: Take the missed dose as soon as you remember, unless it is close to the time of the next scheduled dose. Do not double the dose.
Overdose: Symptoms may include nausea, vomiting, and abdominal pain. If an overdose is suspected, seek emergency medical care; supportive care is the mainstay of treatment.
Discontinuation: For long-term users, the medication can generally be stopped abruptly, but if it has been used for more than six months, a gradual taper may be considered to reduce the risk of rebound acid hypersecretion.
This article provides educational information about Dexilant and is not a substitute for professional medical advice. Treatment decisions, including the use of unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
